Literature DB >> 24993340

Role of immune system in type 1 diabetes mellitus pathogenesis.

Leszek Szablewski1.   

Abstract

The immune system is the body's natural defense system against invading pathogens. It protects the body from infection and works to communicate an individual's well-being through a complex network of interconnected cells and cytokines. This system is an associated host defense. An uncontrolled immune system has the potential to trigger negative complications in the host. Type 1 diabetes results from the destruction of pancreatic β-cells by a β-cell-specific autoimmune process. Examples of β-cell autoantigens are insulin, glutamic acid decarboxylase, tyrosine phosphatase, and insulinoma antigen. There are many autoimmune diseases, but type 1 diabetes mellitus is one of the well-characterized autoimmune diseases. The mechanisms involved in the β-cell destruction are still not clear; it is generally believed that β-cell autoantigens, macrophages, dendritic cells, B lymphocytes, and T lymphocytes are involved in the β-cell-specific autoimmune process. It is necessary to determine what exact factors are causing the immune system to become unregulated in such a manner as to promote an autoimmune response.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diabetes mellitus; HLA; Immunity; Leukocytes

Mesh:

Substances:

Year:  2014        PMID: 24993340     DOI: 10.1016/j.intimp.2014.06.033

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  22 in total

Review 1.  Positive evidence for vitamin A role in prevention of type 1 diabetes.

Authors:  Somaye Yosaee; Maryam Akbari Fakhrabadi; Farzad Shidfar
Journal:  World J Diabetes       Date:  2016-05-10

2.  Restricted MHC class I A locus diversity in olive and hybrid olive/yellow baboons from the Southwest National Primate Research Center.

Authors:  Rebecca A Morgan; Julie A Karl; Hailey E Bussan; Katelyn E Heimbruch; David H O'Connor; Dawn M Dudley
Journal:  Immunogenetics       Date:  2018-03-28       Impact factor: 2.846

3.  Monocytes of newly diagnosed juvenile DM1 patients are prone to differentiate into regulatory IL-10+ M2 macrophages.

Authors:  Ulana Juhas; Monika Ryba-Stanisławowska; Agnieszka Brandt-Varma; Małgorzata Myśliwiec; Jolanta Myśliwska
Journal:  Immunol Res       Date:  2019-02       Impact factor: 2.829

4.  PCGA: a comprehensive web server for phenotype-cell-gene association analysis.

Authors:  Chao Xue; Lin Jiang; Miao Zhou; Qihan Long; Ying Chen; Xiangyi Li; Wenjie Peng; Qi Yang; Miaoxin Li
Journal:  Nucleic Acids Res       Date:  2022-05-26       Impact factor: 19.160

5.  Detection of Circulating Auto-Antibodies Against Ribosylated-LDL in Diabetes Patients.

Authors:  Firoz Akhter; M Salman Khan; Mohammad Faisal; Abdulrahman A Alatar; Saheem Ahmad
Journal:  J Clin Lab Anal       Date:  2016-08-26       Impact factor: 2.352

6.  Host and Environmental Factors Influencing Individual Human Cytokine Responses.

Authors:  Rob Ter Horst; Martin Jaeger; Sanne P Smeekens; Marije Oosting; Morris A Swertz; Yang Li; Vinod Kumar; Dimitri A Diavatopoulos; Anne F M Jansen; Heidi Lemmers; Helga Toenhake-Dijkstra; Antonius E van Herwaarden; Matthijs Janssen; Renate G van der Molen; Irma Joosten; Fred C G J Sweep; Johannes W Smit; Romana T Netea-Maier; Mieke M J F Koenders; Ramnik J Xavier; Jos W M van der Meer; Charles A Dinarello; Norman Pavelka; Cisca Wijmenga; Richard A Notebaart; Leo A B Joosten; Mihai G Netea
Journal:  Cell       Date:  2016-11-03       Impact factor: 41.582

Review 7.  Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?

Authors:  Gustavo Ortiz; Juan P Salica; Eduardo H Chuluyan; Juan E Gallo
Journal:  Biol Res       Date:  2014-11-18       Impact factor: 5.612

8.  Genetic risk analysis of a patient with fulminant autoimmune type 1 diabetes mellitus secondary to combination ipilimumab and nivolumab immunotherapy.

Authors:  Jared R Lowe; Daniel J Perry; April K S Salama; Clayton E Mathews; Larry G Moss; Brent A Hanks
Journal:  J Immunother Cancer       Date:  2016-12-20       Impact factor: 13.751

9.  Th1/Th2 cytokines in Type 1 diabetes: Relation to duration of disease and gender.

Authors:  Hajar Vaseghi; Zohreh Jadali
Journal:  Indian J Endocrinol Metab       Date:  2016 May-Jun

10.  Type 1 Diabetic Populations Have an Increased Prevalence of Parietal Cell Antibody: A Systematic Review and Meta-Analysis.

Authors:  Xi-Feng Pan; Jian-Qiu Gu; Zhong-Yan Shan
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.